← back to search

Judit Boda‐Heggemann

Heidelberg University · DE
Area of research
Radiation · Hepatology
Research interest
Research interests include Advanced Radiotherapy Techniques, Hepatocellular Carcinoma Treatment and Prognosis, Medical Imaging Techniques and Applications, and Cardiac Arrhythmias and Treatments.
h-index
33
citations
3,446
works
216
NIH funding
primary concept
email

Recent publications

Stereotactic body radiotherapy for spine and non-spine bone metastases in prostate carcinoma – a multicenter cohort analysis
Journal of bone oncology 2025cited by 4position: middledoi
Structured Magnetic Resonance Imaging Assessment Improves Diagnosis of Pathological Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation
Oncology Research and Treatment 2025cited by 2position: middledoi
Impact of target volume and dose concepts on the outcomes of prostate cancer patients treated with stereotactic body radiotherapy for spinal metastases − a European multicenter cohort study
Radiotherapy and Oncology 2025cited by 2position: middledoi
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Zeitschrift für Gastroenterologie 2025cited by 1position: middledoi
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Kurzversion
Zeitschrift für Gastroenterologie 2025cited by 1position: middledoi
S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion
Zeitschrift für Gastroenterologie 2025cited by 1position: middledoi
S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Kurzversion
Zeitschrift für Gastroenterologie 2025cited by 0position: middledoi
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
Zeitschrift für Gastroenterologie 2024cited by 8position: middledoi
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion
Zeitschrift für Gastroenterologie 2024cited by 3position: middledoi
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0
Zeitschrift für Gastroenterologie 2024cited by 3position: middledoi
Metastasis-directed stereotactic radiotherapy in patients with breast cancer: results of an international multicenter cohort study
Clinical & Experimental Metastasis 2024cited by 1position: middledoi
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion
Zeitschrift für Gastroenterologie 2024cited by 1position: middledoi
STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe
EP Europace 2023cited by 68position: middledoi
Radiosurgery for ventricular tachycardia (RAVENTA): interim analysis of a multicenter multiplatform feasibility trial
Strahlentherapie und Onkologie 2023cited by 31position: middledoi
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Zeitschrift für Gastroenterologie 2023cited by 4position: middledoi
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome
Zeitschrift für Gastroenterologie 2023cited by 4position: middledoi
Planning Benchmark Study for Stereotactic Body Radiation Therapy of Liver Metastases: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery
International Journal of Radiation Oncology*Biology*Physics 2022cited by 15position: middledoi
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis
International Journal of Cancer 2021cited by 35position: lastdoi
In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)
Scientific Reports 2021cited by 26position: middledoi
The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases
BMC Cancer 2019cited by 96position: middledoi
Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy
Radiotherapy and Oncology 2018cited by 45position: middledoi
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
Radiotherapy and Oncology 2017cited by 61position: middledoi
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma—a multicenter analysis of the German working group “Stereotactic Radiotherapy”
Journal of Thoracic Disease 2017cited by 51position: middledoi
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases—A pooled analysis of the German working group “stereotactic radiotherapy”
Lung Cancer 2016cited by 160position: middledoi
Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy
Radiotherapy and Oncology 2015cited by 125position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Oliver Blanck · Friedrich-Alexander-Universität Erlangen-Nürnberg6 papers (2017–2025)Matthias Gückenberger · Stadtspital Waid3 papers (2017–2021)Fabian Lohaus · German Cancer Research Center3 papers (2017–2025) · 2 papers (2017–2018)Michael Flentje · Ludwig-Maximilians-Universität München2 papers (2017–2018)Klaus-Henning Kahl · Technical University of Munich2 papers (2017–2018)David Krug · University Hospital Heidelberg2 papers (2023–2024)Nicolaus Andratschke · University Hospital of Zurich2 papers (2018–2021)Marciana Nona Duma · Technical University of Munich2 papers (2017–2018)R. Krempien · University Hospital Heidelberg2 papers (2017–2018)Daniel Buergy · Heidelberg University2 papers (2023–2024)Guido Hildebrandt · University Hospital and Clinics2 papers (2017–2018)Juliane Hoerner‐Rieber · Düsseldorf University Hospital2 papers (2017–2018)Frederick Mantel · University Hospital Heidelberg2 papers (2017–2021)Eleni Gkika · Deutschen Konsortium für Translationale Krebsforschung2 papers (2021–2024)Michael J. Eble · University Hospital Heidelberg2 papers (2017–2018)Alexander Hertel · University Hospital Heidelberg1 papers (2025–2025)Heiko Karle · Johannes Gutenberg University Mainz1 papers (2024–2024)Stephan Hohmann · Medizinische Hochschule Hannover1 papers (2023–2023) · 1 papers (2018–2018)